Open AccessThe emergence of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis patients on inhaled antibiotics
Author(s) -
Atqah AbdulWahab,
K. Zahraldin,
Mazen A. Sid Ahmed,
Sulieman Abu Jarir,
M. Muneer,
Shehab Mohamed,
Jemal M Hamid,
Abdallah Hassan,
Emad Ibrahim
Publication year - 2017
Publication title -
lung india
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 25
eISSN - 0974-598X
pISSN - 0970-2113
DOI - 10.4103/lungindia.lungindia_39_17
Subject(s) - medicine , colistin , tobramycin , cefepime , amikacin , piperacillin , pseudomonas aeruginosa , tazobactam , meropenem , ciprofloxacin , sputum , cystic fibrosis , multiple drug resistance , antibiotic resistance , antibiotics , microbiology and biotechnology , gentamicin , imipenem , tuberculosis , biology , pathology , genetics , bacteria
Multidrug-resistant Pseudomonas aeruginosa (MDR-PA) is an important and growing issue in the care of patients with cystic fibrosis (CF), and a major cause of morbidity and mortality.